A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity

StatusNot Yet Recruiting
PhasePhase 1
SponsorPfizer
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Pfizer
438 trials monitored
See 32 trials at risk
Obesity
3,888 trials monitored
See 157 trials at risk
This is a single dose study to learn how safe and effective the study medicine is using different delivery systems for adults with overweight or obesity. Overweight or obesity means having more body fat than what is healthy. The study involves multiple clinic visits at a study site over the length of the study.
Trial Details
NCT Number NCT07876531
Lead Sponsor Pfizer
Conditions
(from sponsor)		 Overweight and/or Obesity, Healthy Participants
Related terms Obesity, Overweight
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov